Answer:
The cell theory states
Explanation:
1/ all living organism are made up of cells: which can be unicellular or multicellular organisms.
2/ cells are the basic structural and functional usnits for living things: so as it was was mentioned in 1, an unicellular organism in consisited of one cell which will be probably functioning, and for multlicellular organisms they contain more than one of functioning cell.
3/ all cells comes from pre-existing cells: the process of which cells reproduce is by splitting the existing cell into 2 cells, or in some cases grow a part of it until it becomes a fully functioning cells, which is dependent on the original cell until it becomes independent.
Answer:
Pretty confident the answer is B.
Explanation:
Answer:
B) They are considered stable over a life time.
Explanation:
It's a little to general to say they are stable over a life time, since it depends on all the other elements of a quality life stated in your other multiple choice options. Just because you lived your life doesn't mean it's now stable. Hopefully this helped!
Double-blind design: this is how the study will be conducted. This means that in this study, participants will know which treatments are being applied to each participant. In this case, the researcher can hire a doctor or health professional who can deliver the different treatments to the participants without the researcher and the participants themselves knowing what treatment is being delivered and which participants are not receiving any treatment.
Antagonist: It will be a substance used to establish connections in the participants' neurological receptors, but without activating these receptors and preventing any other substance from activating them.
Acetylcholine: Will be the neurotransmitter tested in treatments, as it is the main neurotransmitter often related to the symptoms of Parkinson's disease, alzheimer's disease, multiple sclerosis and schizophrenia
Positron Emission Tomography (PET): It will allow the visualization of images that will allow the evaluation of the functioning of the neurotransmitters related to each tested treatment.
Blood-brain barrier: It will allow the assessment of the metabolic function of the participants' brain, as it protects the nervous system from toxic and harmful substances. This cerebral metabolic function will be evaluated in relation to each treatment applied.
Myelin sheath: is the protective layer of nerve cells. It is usually damaged in people who have Parkinson's disease, alzheimer's disease, multiple sclerosis and schizophrenia, for this reason, it will allow the assessment of their protection in relation to each treatment tested.
